Clinical Trials Browser

Phase 1/2 × INDUSTRY × HMPL-013 × Clear all

Advanced Solid Tumors

NCT05565417 2025-10-16

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

BreastGastrointestinalHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

NCT03903705 2025-04-06

: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors

Phase 1/2 Completed

348 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT01975077 2020-02-17

A Phase Ib Study of Fruquintinib in 3rd Line mCRC

Phase 1/2 Completed

62 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

: A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors

A Phase Ib Study of Fruquintinib in 3rd Line mCRC